Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 1 19Phase 3 13Phase 1/2 7Phase 4 2Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15Stomach Neoplasms 11Colonic Neoplasms 7Carcinoma, Hepatocellular 7Rectal Neoplasms 4Pancreatic Neoplasms 3Neoplasms 3Biliary Tract Neoplasms 3Lymphoma, Large B-Cell, Diffuse 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Adenocarcinoma 2Vipoma 1Somatostatinoma 1Resected Liver Metastases From Colorectal Cancer 1Recurrence 1Quality of Life 1Pathologic Complete Response 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Neoplasms 1Insulinoma 1Immunotherapy Gastrict Cancer 1HER2-positive Gastric Cancer 1Glucagonoma 1Gastroesophageal Junction Adenocarcinoma 1Gastrinoma 1Esophageal Squamous Cell Carcinoma 1

Interventions

Gemcitabine 5Capecitabine 4pembrolizumab 3Fluorouracil 3Cisplatin 3vinflunine 2enzalutamide 2cabazitaxel 2abiraterone 2Ipilimumab 2Haloperidol 2Androgen Antagonists 2vedolizumab 1trifluridine tipiracil drug combination 1relugolix 1racemetyrosine 1nimotuzumab 1nilutamide 1lanreotide 1histrelin 1futibatinib 1exemestane 1dexamethasone acetate 1dexamethasone 21-phosphate 1bicalutamide 1beta-Glucans 1auricularum 1atezolizumab 1apatinib 1apalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Neoplasm Metastasis × Oxaliplatin × Clear all
NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Odense University Hospital

Phase 2/3 Completed
116 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡